2021 EASD Performance Evaluation for Infinovo i3 CGM system by Dr. Meng

2021 EASD Performance Evaluation for Infinovo i3 CGM system
Dr. Meng introduced The Performance evaluation of the Glunovo® continuous blood glucose monitoring system in Chinese participants with diabetes the Infinovo CGM (Continuous Glucose Monitoring system)
The Glunovo® CGMS showed high accuracy in both monitoring real-time continuous changes and predicting varying trends in blood glucose level. Glunovo® CGMS had excellent accuracy and limited clinical risk compared with venous blood glucose in range of 2.2-22.2 mmol/L over 14 days.